Hatteras
Venture capitalRaleigh · Late Stage
Fund manager profile
Hatteras is a venture fund manager based in Raleigh. SEC filings show 1 venture fund on record, most recently Hatteras Opportunity Fund I, LP ($125M offering) filed March 2024.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 5 of 5 portfolio companiesBiotech ×4AI & Machine Learning ×2Healthtech ×2Medical Devices ×2Deep Tech ×1Enterprise Software ×1Fintech ×1Retail Tech ×1
HQs:United States×5
Investments · 5 tracked
founders shown can be your intro path
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Charles Deignan(Executive Officer)Glenn Noronha(Executive Officer)Daniel H. White(Executive Officer, Director)Mark Prausnitz(Director)
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Board seatClay B. Thorp· per SEC Form D · $320K raise · filed Oct 2016
Co-investorsHEALTHCARE ROYALTY PARTNERSMountain Group CapitalSolasta VenturesHatteras Venture Partners
Incyclix Bio develops precision cancer treatments targeting the CDK family of enzymes to restore cell cycle control in tumors, including CDK targets beyond CDK4/6 such as CDK2.
BiotechHealthtechDurham, US
Patrick Roberts(Executive Officer and member of the Board of Managers.)
BoardFredric N. Eshelman(Executive Officer and member of the Board of Managers.)Sid Subramony(Member of the Board of Managers.)Norman Sharpless(Member of the Board of Managers.)
Co-investorsCape Fear BioCapitalEshelman Ventures, LLCHatteras Venture Partners
Perfuse Therapeutics is a biotechnology company developing a therapy to improve blood flow to the retina, targeting ocular diseases such as glaucoma and diabetic retinopathy.
BiotechMedical DevicesSan Francisco, US
BoardChristy Shaffer(Director)Chau Khuong(Director)inSevgi Gurkan(Executive Officer, Director, Promoter)in
Co-investorsAccess BiotechnologyCatalio Capital Management, LPHatteras Venture PartnersLAVLilly Asia VenturesOrbiMed
Santé builds a point-of-sale system designed specifically for liquor retail stores.
AI & Machine LearningEnterprise SoftwareFintechRetail TechSaaSNew York City, US
Darren Fike(Founder)in
Co-investorsBonfire VenturesKima VenturesOperator CollectiveTrail Run CapitalVeridical VenturesY Combinator+2 more
Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.
AI & Machine LearningBiotechDeep TechDurham, US
Mark A. Hallen(Executive Officer, Director)Marcel Frenkel(Executive Officer, Director)Damien Petty(Director)Jia Wei Xu(Director)
Co-investorsCape Fear BioCapitalDFJ DragonFundDraper AssociatesDuke Capital PartnersHatteras Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesSanté · pulse2.com · Jul 19, 2026
Perfuse Therapeutics · bizjournals.com · Jun 29, 2026
Incyclix Bio · clinicaltrialvanguard.com · Apr 10, 2026
Clearside Biomedical · elevenflo.com · Mar 6, 2026
Frequently asked questions
- What stage does Hatteras invest at?
- Hatteras invests at the Late Stage stage.
- Where is Hatteras located?
- Hatteras is headquartered in Raleigh, US.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.